Results 161 to 170 of about 1,152,275 (289)

L'Expertise Milano

open access: yes
Quando l’Alfa Romeo era Milano potrebbe sembrare, sulle prime, un titolo provocatorio che prende spunto dalle recenti vicende che hanno visto la stessa Alfa Romeo costretta a cambiare il nome del suo ultimo modello da “Milano” in “Junior”, proprio a ...
Marco Turinetto
core  

Exploring the cranial morphology and possible convergences of Triassic non‐crocodylomorph pseudosuchians (Archosauria: Pseudosuchia) with other sauropsids through linear morphometrics

open access: yesThe Anatomical Record, EarlyView.
Abstract Triassic pseudosuchians had highly diversified cranial morphologies. These archosaurs occupied diverse ecological roles, ranging from terrestrial predators and herbivores to semiaquatic ambush predators and possible waders. Here, we apply linear cranial morphometrics to assess possible convergences with other sauropsids from the clades ...
Rafael Terras   +3 more
wiley   +1 more source

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

open access: yesAnimal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali   +10 more
wiley   +1 more source

The Germline SH2B3<sup>rs111340708</sup> Splicing Variant Drives Intron Retention and Protein Instability by Impacting Clinical Outcomes in Core Binding Factor AML. [PDF]

open access: yesHematol Oncol
Stefanucci MR   +9 more
europepmc   +1 more source

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

open access: yesArthritis &Rheumatology, EarlyView.
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis   +22 more
wiley   +1 more source

Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets. [PDF]

open access: yesESMO Open
Rametta A   +13 more
europepmc   +1 more source

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo   +7 more
wiley   +1 more source

Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner   +52 more
wiley   +1 more source

Home - About - Disclaimer - Privacy